21世纪临床全身磁共振成像(WB-MRI)的新进展
本文综述全身磁共振成像(WB-MRI)自1970年代问世以来的发展,重点介绍扩散加权成像(DWI)的应用、硬件软件进步使扫描时间缩短至40-50分钟,以及其在肿瘤学、儿科、风湿与肌骨疾病和人群筛查中应用增加的背景;同时提及PET-MRI混合成像与人工智能/机器学习对缩短采集与分析时间的前景。
要点
- DWI为WB-MRI提供优异的病灶-背景对比,可检出5-10 mm的局灶性病灶。
- 硬件与软件进步将WB-MRI采集时间缩短至40-50分钟。
- WB-MRI可用于追踪肿瘤患者的疾病演变和监测反应异质性。
关键影像表现/征象
- DWI提供优异的病灶-背景对比,在可接受的空間分辨率下可检出5-10 mm的局灶性病灶。
临床应用与阅片要点
- 作者指出WB-MRI可用于追踪疾病演变和监测癌症患者的反应异质性。
- 作者指出可将WB-MRI与PET-MRI分子成像结合以发挥混合成像的优势。
- 作者指出人工智能和机器学习将缩短图像采集时间和图像分析时间,使该技术相较其他成像技术更具竞争力。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Whole-body MRI (WB-MRI) has evolved since its first introduction in the 1970s as an imaging technique to detect and survey disease across multiple sites and organ systems in the body. The development of diffusion-weighted MRI (DWI) has added a new dimension to the implementation of WB-MRI on modern scanners, offering excellent lesion-to-background contrast, while achieving acceptable spatial resolution to detect focal lesions 5 to 10 mm in size. MRI hardware and software advances have reduced acquisition times, with studies taking 40-50 min to complete.The rising awareness of medical radiation exposure coupled with the advantages of MRI has resulted in increased utilization of WB-MRI in oncology, paediatrics, rheumatological and musculoskeletal conditions and more recently in population screening. There is recognition that WB-MRI can be used to track disease evolution and monitor response heterogeneity in patients with cancer. There are also opportunities to combine WB-MRI with molecular imaging on PET-MRI systems to harness the strengths of hybrid imaging. The advent of artificial intelligence and machine learning will shorten image acquisition times and image analyses, making the technique more competitive against other imaging technologies.
引用
- Tunariu N, Blackledge M, Messiou C, et al. What's New for Clinical Whole-body MRI (WB-MRI) in the 21st Century. Br J Radiol. 2020. PMID: 32822545. doi:10.1259/bjr.20200562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。